NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

We are fortunate to receive case studies leading into the conference.

Remember that slow period? Look at the current numbers.

This is not a trial with 5,000 patients and a company reporting on one patient. This trial (in my best estimate) is somewhere between 20-30 participants currently receiving injections (with 10-15 of those patients too early in the process to have data available yet). -- Hodge

Now that we are in the fast period. It makes absolute sense to give a few quality case studies leading into the conference, then at the conference, release the cumulative data.

I apologize in advance for my certainty on this, but given the current treatment stage for the enrollment population, this is exactly what they should do.

I am grateful to be receiving updates.